The epidermal growth factor receptor as a target for colorectal cancer therapy

This publication has 57 references indexed in Scilit:

• Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor Receptor
  Journal of Clinical Oncology, 2004
• Selective abrogation of the proinvasive activity of the trefoil peptides pS2 and spasmolytic polypeptide by disruption of the EGF receptor signaling pathways in kidney and colonic cancer cells
  Oncogene, 2003
• The EGFR as a target for anticancer therapy—focus on cetuximab
  European Journal Of Cancer, 2001
• Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis, and cooperate with cytotoxic drugs in human cancer cell lines
  International Journal of Cancer, 2001
• Inhibition of epidermal growth factor receptor kinase induces protease-dependent apoptosis in human colon cancer cells
  Gastroenterology, 1998
• A role for epidermal growth factor receptor, c-Src and focal adhesion kinase in an in vitro model for the progression of colon cancer
  Oncogene, 1997
• Expression of EGF, EGF‐receptor, p53, v‐erb B and ras p21 in colorectal neoplasms by immunostaining paraffin‐embedded tissues
  Pathology International, 1994
• Infection with a transforming growth factor α anti‐sense retroviral expression vector reduces the in vitro growth and transformation of a human colon cancer cell line
  International Journal of Cancer, 1993
• Correlation of epidermal growth factor receptor and c-erbB2 oncogene product to known prognostic indicators of colorectal cancer
  Surgical Oncology, 1992
• Epidermal growth factor receptor expression in colorectal cancer
  British Journal of Surgery, 1990